tetano
Editor, Senior Moderator
Clin Nucl Med
. 2020 Jun 8.
doi: 10.1097/RLU.0000000000003152. Online ahead of print.
COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab
Carlos Artigas[SUP] 1 [/SUP], Marc Lemort[SUP] 2 [/SUP], Fabienne Mestrez[SUP] 3 [/SUP], Thierry Gil[SUP] 4 [/SUP], Patrick Flamen[SUP] 1 [/SUP]
Affiliations
Abstract
Within a few months, coronavirus disease 2019 (COVID-19) has become a pandemic with more than 2 million patients infected and a high mortality rate. Early detection of COVID-19 in oncologic patients is crucial in order to rapidly apply isolation measures and avoid nosocomial spread. However, early diagnosis may be challenging, especially in cancer patients under treatment with immunotherapy as drug-induced pneumonitis can present similar clinical and radiological features. We describe the findings of a SARS-CoV-2 infection on PET/CT with F-FDG in a 51-year-old man with metastatic renal cell carcinoma under treatment with nivolumab.
. 2020 Jun 8.
doi: 10.1097/RLU.0000000000003152. Online ahead of print.
COVID-19 Pneumonia Mimicking Immunotherapy-Induced Pneumonitis on 18F-FDG PET/CT in a Patient Under Treatment With Nivolumab
Carlos Artigas[SUP] 1 [/SUP], Marc Lemort[SUP] 2 [/SUP], Fabienne Mestrez[SUP] 3 [/SUP], Thierry Gil[SUP] 4 [/SUP], Patrick Flamen[SUP] 1 [/SUP]
Affiliations
- PMID: 32520508
- DOI: 10.1097/RLU.0000000000003152
Abstract
Within a few months, coronavirus disease 2019 (COVID-19) has become a pandemic with more than 2 million patients infected and a high mortality rate. Early detection of COVID-19 in oncologic patients is crucial in order to rapidly apply isolation measures and avoid nosocomial spread. However, early diagnosis may be challenging, especially in cancer patients under treatment with immunotherapy as drug-induced pneumonitis can present similar clinical and radiological features. We describe the findings of a SARS-CoV-2 infection on PET/CT with F-FDG in a 51-year-old man with metastatic renal cell carcinoma under treatment with nivolumab.